Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT00895414Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer
NCT05708703Assessing the Time Demands of Cancer
NCT01634217Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
NCT00167180Post Transplant Donor Lymphocyte Infusion
NCT03678493A Study of FMT in Patients With AML Allo HSCT in Recipients
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT03789721Adrenoleukodystrophy National Registry Study
NCT05308316Sugars in Cigarettes
NCT04003805Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
NCT01685411Busulfan and Cyclophosphamide Followed By ALLO BMT
NCT00295880Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT01343368Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT04630769FT516 and IL2 With Enoblituzumab for Ovarian Cancer
NCT03316456Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
NCT06693986Adenovirus (RGDCRAdCOX2F)
NCT01385423Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
NCT00726739Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
NCT02141451ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
NCT01158456Metabolism of NNK Among African Americans
NCT01526603High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
NCT05805605Allo HSCT Using RIC and PTCy for Hematological Diseases
NCT05123040Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT00748163Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
NCT02410239MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
NCT01572636Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
NCT01626092Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT06411795Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
NCT05700630Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
NCT03557749Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT01677949Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
NCT00365547Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
NCT03294304BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
NCT00612716Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
NCT01400672Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT00638547Intrathecal Enzyme Replacement for Hurler Syndrome
NCT07008638Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
NCT00478244Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
NCT07070726UNTOLD Ovarian Cancer Unmet Needs Survey
NCT01181258Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT01207076AHN-12 Biodistribution in Advanced Leukemia